Antibodies that immunospecifically bind to blys

Details for Australian Patent Application No. 2001268427 (hide)

Owner Human Genome Sciences, Inc.

Inventors Ruben, Steven M; Hilbert, David; Choi, Gil H.; Barash, Steven C.; Vaughan, Tristan

Agent Wrays

Pub. Number AU-B-2001268427

PCT Pub. Number WO02/02641

Priority 60240816 17.10.00 US; 60212210 16.06.00 US; 60293499 25.05.01 US; 60276248 16.03.01 US; 60277379 21.03.01 US

Filing date 15 June 2001

Wipo publication date 14 January 2002

Acceptance publication date 29 March 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

Event Publications

11 March 2004 Assignment before Grant

  Human Genome Sciences, Inc.; Cambridge Antibody Technology Group Plc The application has been assigned to Human Genome Sciences, Inc.

29 March 2007 Application Accepted

  Published as AU-B-2001268427

2 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268428

2001268426